NASDAQ:CTMX - CytomX Therapeutics, Inc.
$18.39
 $-0.09
-0.49%
2:40PM EDT
2019-02-15
CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company. The Company uses its Probody technology platform to create cancer immunotherapies against clinically validated targets, as well as to develop cancer therapeutics against difficult-to-drug targets. Its pipeline is focused on the development of therapies in a set of modalities: Probody cancer immunotherapies, Probody drug conjugates, T-cell engaging Probody bispecifics and ProCAR-NK cell therapies. Its product candidates include CX-072, CX-2009, CX-2029, Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and CX-188. Its Probody platform utilizes active proteases in tumor tissue to allow monoclonal antibody-based therapies. Its investigational Probody therapeutics address clinically validated cancer targets in immuno-oncology, such as programmed death-ligand 1, against which CX-072 is directed, as well as targets, such as cluster of differentiation 166, against, which CX-2009 is directed. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  CTMX     avg for
industry  
  avg for
sector  
42 stocks weight:  69. 00   0. 00   0. 00  
42 stocks rank:  2. 32 K 1. 86 K 1. 09 K
# analyst opinions:  9. 00   14. 92   14. 43  
mean recommendation:  1. 60   1. 91   1. 93  

quick ratio:  5. 38   5. 37   1. 81  
current ratio:  5. 48   5. 69   2. 19  

target price low:  21. 00   88. 97   117. 82  
target price avg:  32. 22   115. 19   141. 96  
target price high:  44. 00   143. 40   163. 16  
1-yr high:  34. 22   124. 30   142. 77  
last close:  18. 47   101. 85   127. 84  
50-day avg:  16. 18   98. 27   122. 46  
200-day avg:  19. 80   99. 72   122. 70  
1-yr low:  12. 69   78. 19   100. 16  
volume:  407. 01 K 2. 38 M 4. 64 M
50-day avg volume:  347. 78 K 3. 31 M 4. 94 M
200-day avg volume:  401. 51 K 3. 23 M 4. 28 M

1-day return:  -0. 91 % 0. 22 % 0. 48 %
this week return:  -3. 10 % 1. 77 % 2. 01 %
12-wk return:  39. 50 % 6. 56 % 3. 33 %
52-wk return:  -29. 60 % -2. 23 % 14. 35 %

enterprise value (EV):  393. 27 M 55. 17 B 104. 51 B
market cap:  831. 34 M 49. 01 B 96. 46 B
EBITDA:  -51. 62 M 4. 82 B 7. 18 B
enterprise multiple (EV/EBITDA):  -7. 62   -91. 79   2. 29  
enterprise/revenue (EV/R):  5. 24   29. 84   23. 39  
total revenue:  75. 10 M 11. 28 B 40. 22 B
total debt:  0. 00   13. 73 B 16. 57 B
net income (common):  -51. 75 M 2. 37 B 3. 58 B

shares outstanding:  45. 01 M 607. 99 M 1. 22 B
shares:  41. 29 M 605. 53 M 1. 15 B
shares short:  2. 21 M 11. 62 M 12. 55 M
shares short prior month:  2. 33 M 11. 95 M 13. 44 M
short ratio:  5. 29   4. 82   3. 10  
short % of float:  6. 81 % 6. 19 % 2. 82 %
total cash/share:  10. 32   12. 02   11. 46  
total cash:  464. 56 M 7. 41 B 7. 37 B
free cash flow:  32. 76 M 95. 99 M 2. 04 B
operating cash flow:  -24. 78 M 164. 74 M 3. 04 B

book value:  3. 50   14. 43   28. 26  
price/book:  5. 27   -1. 57   -2. 97  
gross profits:  71. 62 M 8. 28 B 18. 09 B
operating margins:  -70. 98 % -458. 01 % -642. 83 %
EBITDA margins:  -68. 73 % 13. 81 % 22. 47 %
profit margins:  -68. 90 % 6. 57 % 9. 92 %
gross margins:  100. 00 % 49. 33 % 54. 53 %

1-yr max volatility:  25. 10 % --- ---
1-yr mean volatility:  -0. 09 % 0. 01 % 0. 06 %

1-yr EPS:  -1. 29   3. 03   4. 09  
forward EPS:  -2. 27   4. 33   6. 99  
P/E:  -14. 27   6. 11   26. 91  
forward P/E:  -8. 40   8. 38   10. 48  
PE/G:  0. 30   0. 37   5. 61  
growth:  -48. 20 % 683. 72 % 104. 79 %
earnings high:  -0. 22   1. 27   1. 66  
earnings avg:  -0. 48   1. 01   1. 53  
earnings low:  -0. 75   0. 76   1. 40  
revenue high:  28. 15 M 2. 86 B 11. 19 B
revenue avg:  15. 71 M 2. 78 B 10. 84 B
revenue low:  8. 00 M 2. 67 B 10. 64 B
return on assets:  -7. 66 % -3. 27 % 3. 81 %
return on equity:  -50. 95 % 107. 48 % 27. 82 %
revenue growth:  -48. 20 % 648. 36 % 97. 70 %
revenue/share:  1. 88   14. 68   59. 83  

beta (1yr vs S&P500):  1. 73   1. 21   0. 93  
sharpe (1yr):  -0. 37   0. 06   0. 98  

held % insiders:  2. 26 % 6. 46 % 3. 21 %
held % institutions:  86. 68 % 79. 10 % 70. 01 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-14 : CTMX
.    + 3.004 =         3.004 :: INITIAL WEIGHT
.  + 256.388 =       259.391 :: inverse volume-to-price addition
.  + 335.436 =       594.828 :: spline projection addition
.  - 140.242 =       454.586 :: poor performance penalty
.    x 0.802 =       364.413 :: one-year gains+dividend factor
.     x 7.21 =      2627.494 :: 13 weeks' performance factor
.    x 1.492 =      3921.506 :: industry recommendation factor
.    x 2.914 =     11427.484 :: symbol recommendation factor
.    x 1.175 =     13432.928 :: EV/R factor
.    x 0.999 =     13422.635 :: return on assets factor
.    x 0.995 =     13354.247 :: return on equity factor
.    x 0.995 =      13289.88 :: revenue growth factor
.    x 2.962 =     39364.133 :: current ratio factor
.    x 1.108 =     43622.319 :: quick ratio factor
.     x 1.09 =     47567.052 :: short ratio factor
.    x 2.076 =      98745.31 :: price-to-book factor
.    x 1.167 =    115195.336 :: 5-day avg > 50-day avg
.    x 2.078 =    239335.125 :: P/E weight
.    x 1.356 =    324440.487 :: PE/G factor
.    x 1.543 =     500582.89 :: beta factor
.    x 0.374 =    187427.452 :: sharpe factor
.    x 1.377 =    258105.545 :: target low factor
.    x 1.288 =    332338.027 :: target mean factor
.    x 1.118 =    371410.599 :: target high factor
.    x 1.066 =    395779.891 :: industry 12-weeks return
.    x 0.999 =    395545.951 :: overall "drift" factor
.    x 0.749 =    296271.679 :: largest single-day jump factor
.     x 1.01 =    299231.677 :: mean volatility factor
.    x 1.098 =    328424.914 :: 42-day mean volatility factor
.      x 1.0 =    328446.958 :: factor hist industry gain for week 06
.   cubeRoot =        68.996 :: reduced for readability
.                     68.996 :: FINAL WEIGHT for NASDAQ:CTMX


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org